![Foto de MARÍA](/img/nophoto.png)
MARÍA
GALINDO IZQUIERDO
Profesora titular de universidad
Publicaciones (99) Publicaciones de MARÍA GALINDO IZQUIERDO
2024
-
Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?
Rheumatology (Oxford, England), Vol. 63, Núm. 1, pp. 72-78
-
Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study
Lupus, Vol. 33, Núm. 7, pp. 663-674
-
Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus
Reumatologia Clinica, Vol. 20, Núm. 6, pp. 312-319
-
Patient-reported outcome measures for systemic lupus erythematosus: an expert Delphi consensus to guide implementation in routine care
BMC Rheumatology, Vol. 8, Núm. 1
2023
-
Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 58
-
Gender biases in Spanish rheumatology: Perception and facts
Reumatologia Clinica, Vol. 19, Núm. 7, pp. 392-401
-
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs
Rheumatology and Therapy, Vol. 10, Núm. 2, pp. 357-373
-
Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 61
-
Searching for a prognostic index in lupus nephritis
European journal of medical research, Vol. 28, Núm. 1, pp. 19
-
mTOR inhibitors in a patient with lupus nephritis; why not?
Nefrologia
-
mTOR inhibitors in a patient with lupus nephritis; why not?
Nefrologia
2022
-
Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure
Seminars in Arthritis and Rheumatism, Vol. 52
-
Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study
Rheumatology (Oxford, England), Vol. 62, Núm. 1, pp. 217-224
-
Importance of family planning in patients with immune-mediated inflammatory diseases: a multidisciplinary approach
Reumatologia Clinica, Vol. 18, Núm. 4, pp. 200-206
-
SGLT2 inhibitors in lupus nephropathy, a new therapeutic strategy for nephroprotection
Annals of the Rheumatic Diseases, Vol. 81, Núm. 9, pp. 1337-1338
-
Saving the kidneys in the lupus patient: Beyond immunosuppression, the need to collaborate across multiple disciplines
European Journal of Internal Medicine, Vol. 99, pp. 19-21
2021
-
Complement as a Therapeutic Target in Systemic Autoimmune Diseases
Cells, Vol. 10, Núm. 1
-
Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in Spain
Reumatologia Clinica, Vol. 17, Núm. 5, pp. 245-249
-
Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
Clinical and Experimental Rheumatology, Vol. 39, Núm. 3, pp. 555-563
-
Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER)
Rheumatology (Oxford, England), Vol. 60, Núm. 4, pp. 1793-1803